[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
January 13, 1999

Talking With Patients About Screening for Prostate Cancer

Author Affiliations

Margaret A.WinklerMDIndividualAuthorPhil B.FontanarosaMD, Senior EditorsIndividualAuthor

JAMA. 1999;281(2):133. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-2-jac80019

To the Editor: The timely update by Dr Stern and colleagues1 on emerging issues in early detection of prostate and colorectal cancers raised many important points, some of which require clarification and emphasis.

The American Cancer Society (ACS) recognizes that there exist differing opinions as to whether early detection testing for prostate cancer lowers disease-specific mortality. Our updated guidelines of June 1997 advise physicians and other clinicians to offer early-detection testing for prostate cancer to appropriate patients and to provide information to patients on the test's potential risks and benefits.2 The casual reader of the article by Stern et al might erroneously construe that ACS supports "mass" screening.